Search Results 2851-2860 of 18419 for rheumatoid arthritis

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Arthritis, Thyroid cancer, Thyroid nodule, Abscess, Liver problems, Hepatocellular carcinoma, Infection, Bone metastasis, Pneumothorax, Pleural effusion ...

  2. ... ARTHRITIS WITH MCC,69470.41 MS549,SEPTIC ARTHRITIS WITH CC,45971.93 MS551,MEDICAL BACK PROBLEMS WITH MCC,41020.69 MS552,MEDICAL BACK PROBLEMS WITHOUT MCC ...

  3. Mayo Clinic Health Letter: Highlights from the September 2014 Issue

    Stop smoking: Smoking is a risk factor for many surgical complications, including problems with the incision, infections, pneumonia and cardiovascular problems.

  4. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    Clinically significant bleeding within 4 weeks of screening, current use of warfarin, factor Xa inhibitors, and direct thrombin inhibitors unless these ...

  5. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... arthritis, Basilar skull invagination, Neurofibromatosis type 2, Pancoast tumor, Failed back syndrome, Nerve irritation, Brachial plexus avulsion pain ...

  6. Dexamethasone in Total Knee Arthroplasty - Mayo Clinic

    Inflammatory arthritis; Current systemic fungal infection. Renal or liver failure. Prior adverse reaction to corticosteroid. Primary TKA requiring hardware ...

  7. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    ... arthritis, stroke, and Parkinson's disease. The subject is required to take or has taken immunomodulatory/immunosuppressive agents (except IGIV) that ...

  8. Publications - Rebecca L. King, M.D. - Mayo Clinic

    Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma. Hum Pathol. 2022 Jul; 125:2-10. Epub 2022 Apr 12. View PubMed; Desai SH ...

  9. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

    ... factor agents) with the exception of corticosteroid treatment < 20 mg/day prednisone or equivalent within 7 days prior to first dose of ICP-022: Inhaled and ...

  10. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

    (GFR) with a correction factor for African American race creatinine clearance for trial eligibility, where GFR >= 30 mL/min/1.73m^2 will be considered ...